Key words: cervicosacropexy (CESA), vaginosacropexy (VASA), urinary incontinence, overactive bladder syndrome, mixed urinary incontinence, polyvinylidene fluoride tape, uterosacral ligaments.
SummaryBackground. The purpose of our study is to evaluate and present the results of the first cervicosacropexy (CESA) in Lithuania, which was performed in Klaipeda university hospital. Materials and methods. For the 62 years old female patient suffering from overactive bladder syndrome, confirmed by urodynamic test, and II⁰ pelvic organ prolapse (by pelvic organ prolapse quantification classification) cervicosacropexy using polyvinylidene fluoride (PVDF) tape was performed in Klaipeda University Hospital in 2016. Urinary incontinence was evaluated by voiding diary, International Consultation on Incontinence Modular Questionnaire -Short Form (ICIQ-SF) and Overactive Bladder Symptom Score (OABSS), that were filled by the patient before the surgery and 2, 4, 8 weeks after it. Urinary urgency, episodes of urinary incontinence, the need of sanitary pads and urinary frequency were compared before and after the surgery. To assess urinary incontinence impact on daily life, the General King's Health Questionnaire (GKHQ) was used before and after the procedure. Results. After the surgery decrease of episodes of urinary incontinence, urinary frequency during day and night, urinary urgency and the need of sanitary pads were observed. Moreover, the patient could hold the urine longer after feeling the need to urinate.
IntroductionUrge urinary incontinence (UUI) is a bothersome urogenital disorder that affects approximately one third of postmenopausal women. Urgency, frequency and incontinence -this triad has detrimental effects on the patient's quality of life and proves to be a source of anxiety [1]. According to Herzog, Fultz and Thom, about 40 % of all women will develop urinary incontinence during their life, usually starting around the age of 50 [3,4]. This is a debilitating disorder, which massively restricts the social and private life of the patient [5]. Known pharmacological treatment attempts to reduce the urinary incontinence symptoms; however, there is no cure addressing the basic cause of the disease [6]. Moreover, pharmacological treatment is slightly more effective than placebo [7]. Treatment of UUI is now focused on antimuscarinic drug therapy, botulinum intravesical injection, sacral neuromodulation, and behavioral interventions [7]. Despite many known treatment methods of UUI, surgery is not widely practiced.Little is known about causes of UUI. Recent physiological and clinical researches are focused on descriptions and development of etiological theories. The most promising theories indicate abnormalities in control of bladder function resulting from aberrations of neurological signals from the bladder (sensation) as well as signals from continence controlling central and peripheral nervous system [7].In 1991 de Lancey emphasized the importance of the support of the genital tract for continence function [8]. He con...